Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series

Saved in:
Bibliographic Details
Published in:Therapeutics and Clinical Risk Management
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301676239552513
collection WordPress RSS
FRELIP Feed Integration
container_title Therapeutics and Clinical Risk Management
description
discipline_display Emergency and Intensive Critical Care
discipline_facet Emergency and Intensive Critical Care
format Online Article
RSS Article
genre Journal Article
id rss_article:74009
institution FRELIP
journal_source_facet Therapeutics and Clinical Risk Management
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series
Emergency and Intensive Critical Care
General
Emergency and Intensive Critical Care
sub_discipline_display General
sub_discipline_facet General
subject_display Emergency and Intensive Critical Care
General
Emergency and Intensive Critical Care
Emergency and Intensive Critical Care
General
Emergency and Intensive Critical Care
subject_facet Emergency and Intensive Critical Care
General
Emergency and Intensive Critical Care
title Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series
title_auth Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series
title_full Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series
title_fullStr Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series
title_full_unstemmed Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series
title_short Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series
title_sort camrelizumab plus apatinib in advanced unresectable alveolar soft part sarcoma and undifferentiated pleomorphic sarcoma patients: a single-center, exploratory case series
topic Emergency and Intensive Critical Care
General
Emergency and Intensive Critical Care
url https://www.dovepress.com/camrelizumab-plus-apatinib-in-advanced-unresectable-alveolar-soft-part-peer-reviewed-fulltext-article-TCRM